These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14633820)

  • 1. Plasma adiponectin and endogenous glucose production in humans.
    Stefan N; Stumvoll M; Vozarova B; Weyer C; Funahashi T; Matsuzawa Y; Bogardus C; Tataranni PA
    Diabetes Care; 2003 Dec; 26(12):3315-9. PubMed ID: 14633820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.
    Stefan N; Vozarova B; Funahashi T; Matsuzawa Y; Weyer C; Lindsay RS; Youngren JF; Havel PJ; Pratley RE; Bogardus C; Tataranni PA
    Diabetes; 2002 Jun; 51(6):1884-8. PubMed ID: 12031977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.
    Tschritter O; Fritsche A; Thamer C; Haap M; Shirkavand F; Rahe S; Staiger H; Maerker E; Häring H; Stumvoll M
    Diabetes; 2003 Feb; 52(2):239-43. PubMed ID: 12540592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin in a native Canadian population experiencing rapid epidemiological transition.
    Hanley AJ; Connelly PW; Harris SB; Zinman B
    Diabetes Care; 2003 Dec; 26(12):3219-25. PubMed ID: 14633805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity.
    Ryan AS; Berman DM; Nicklas BJ; Sinha M; Gingerich RL; Meneilly GS; Egan JM; Elahi D
    Diabetes Care; 2003 Aug; 26(8):2383-8. PubMed ID: 12882866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.
    Vozarova de Courten B; Degawa-Yamauchi M; Considine RV; Tataranni PA
    Diabetes; 2004 May; 53(5):1279-84. PubMed ID: 15111497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia.
    Stefan N; Bunt JC; Salbe AD; Funahashi T; Matsuzawa Y; Tataranni PA
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4652-6. PubMed ID: 12364452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
    Stefan N; Kovacs P; Stumvoll M; Hanson RL; Lehn-Stefan A; Permana PA; Baier LJ; Tataranni PA; Silver K; Bogardus C
    Diabetes; 2003 Jun; 52(6):1544-50. PubMed ID: 12765968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.
    Krakoff J; Funahashi T; Stehouwer CD; Schalkwijk CG; Tanaka S; Matsuzawa Y; Kobes S; Tataranni PA; Hanson RL; Knowler WC; Lindsay RS
    Diabetes Care; 2003 Jun; 26(6):1745-51. PubMed ID: 12766104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
    Weyer C; Funahashi T; Tanaka S; Hotta K; Matsuzawa Y; Pratley RE; Tataranni PA
    J Clin Endocrinol Metab; 2001 May; 86(5):1930-5. PubMed ID: 11344187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.
    Pellmé F; Smith U; Funahashi T; Matsuzawa Y; Brekke H; Wiklund O; Taskinen MR; Jansson PA
    Diabetes; 2003 May; 52(5):1182-6. PubMed ID: 12716750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration.
    Weyer C; Tataranni PA; Pratley RE
    Diabetes Care; 2000 Jun; 23(6):779-85. PubMed ID: 10840996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adiponectin levels are not associated with fat oxidation in humans.
    Stefan N; Vozarova B; Funahashi T; Matsuzawa Y; Ravussin E; Weyer C; Tataranni PA
    Obes Res; 2002 Oct; 10(10):1016-20. PubMed ID: 12376582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance.
    Oberbach A; Tönjes A; Klöting N; Fasshauer M; Kratzsch J; Busse MW; Paschke R; Stumvoll M; Blüher M
    Eur J Endocrinol; 2006 Apr; 154(4):577-85. PubMed ID: 16556721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.